Search results
Results from the WOW.Com Content Network
As early as 2016, the Obama administration had begun to focus on the risks and regulations for artificial intelligence. In a report titled Preparing For the Future of Artificial Intelligence, [153] the National Science and Technology Council set a precedent to allow researchers to continue to develop new AI technologies with few restrictions ...
Discussions on regulation of artificial intelligence in the United States have included topics such as the timeliness of regulating AI, the nature of the federal regulatory framework to govern and promote AI, including what agency should lead, the regulatory and governing powers of that agency, and how to update regulations in the face of rapidly changing technology, as well as the roles of ...
The investment firm Bessemer Venture Partners has identified some 20 health-focused AI startups on track to make $10 million in revenue each in a year. The FDA has approved nearly a thousand ...
Regulation of algorithms, or algorithmic regulation, is the creation of laws, rules and public sector policies for promotion and regulation of algorithms, particularly in artificial intelligence and machine learning. [1] [2] [3] For the subset of AI algorithms, the term regulation of artificial intelligence is used.
The laws governing artificial intelligence are increasingly different depending on where you are in the US, a mounting source of confusion for businesses racing to capitalize on the rise of AI ...
May 3—COLUMBUS — The Ohio Third Frontier Commission has approved $2.65 million in grants to support the research and licensing of new technologies. Two research institutions will receive grant ...
Artificial intelligence in pharmacy is the application of artificial intelligence (AI) [118] [119] [120] to the discovery, development, and the treatment of patients with medications. [121] AI in pharmacy practices has the potential to revolutionize all aspects of pharmaceutical research as well as to improve the clinical application of ...
The US system of healthcare is highly complex and fragmented, with use of multiple information technology systems and vendors incorporating different standards. In contrast with other developed nations, healthcare accounts for a disproportionate percentage of the US GDP, and there is a concern about the economic viability of Medicare. [3]